ClearPoint Neuro, Inc. (CLPT)
NASDAQ: CLPT · Real-Time Price · USD
15.27
+1.08 (7.61%)
At close: Jan 6, 2026, 4:00 PM EST
15.37
+0.10 (0.65%)
Pre-market: Jan 7, 2026, 4:08 AM EST
ClearPoint Neuro Market Cap
ClearPoint Neuro has a market cap or net worth of $454.26 million as of January 7, 2026. Its market cap has increased by 9.20% in one year.
Market Cap
454.26M
Enterprise Value
451.78M
1-Year Change
9.20%
Ranking
Category
Stock Price
$15.27
Market Cap Chart
Since May 22, 2012, ClearPoint Neuro's market cap has increased from $30.30M to $454.26M, an increase of 1,399.20%. That is a compound annual growth rate of 21.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 6, 2026 | 434.00M | 11.63% |
| Dec 31, 2025 | 388.80M | -8.37% |
| Dec 31, 2024 | 424.30M | 153.77% |
| Dec 29, 2023 | 167.20M | -19.62% |
| Dec 30, 2022 | 208.00M | -21.57% |
| Dec 31, 2021 | 265.20M | -1.08% |
| Dec 31, 2020 | 268.10M | 267.26% |
| Dec 31, 2019 | 73.00M | 337.13% |
| Dec 31, 2018 | 16.70M | -41.61% |
| Dec 29, 2017 | 28.60M | 132.52% |
| Dec 30, 2016 | 12.30M | -56.84% |
| Dec 31, 2015 | 28.50M | -41.84% |
| Dec 31, 2014 | 49.00M | -42.22% |
| Dec 31, 2013 | 84.80M | 10.42% |
| Dec 31, 2012 | 76.80M | 153.47% |
| May 22, 2012 | 30.30M | - |
View and export this data all the way back to 2012. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 967.33B |
| Johnson & Johnson | 499.57B |
| AbbVie | 405.28B |
| UnitedHealth Group | 304.72B |
| AstraZeneca | 284.35B |
| Novartis AG | 266.00B |
| Merck & Co. | 264.21B |
| Novo Nordisk | 230.76B |